Axilum Robotics was founded in 2011 in Strasbourg, France, by a team of leading experts in medical robotics. The objective of the company is to provide researchers and health care professionals with robotic solutions to improve both technical medical procedures and medical resources management. In 2013, the company launched TMS-Robot, the first CE marked medical robot specifically designed for Transcranial Magnetic Stimulation. TMS is a rapidly expanding non-invasive neurostimulation technique with therapeutic applications in drug resistant psychiatric and neurological diseases, like major depression, chronic pain, stroke rehabilitation. With its patented hemispherical architecture, TMS-Robot is intended to safely automate and improve the accuracy and repeatability of this non-invasive and painless brain stimulation technique, which is usually implemented manually In 2018, Axilum Robotics has reinforced its expertise in medical robotics with the launch of a new robotic platform using collaborative robotic technology. This new platform allows Axilum Robotics to extend its range of robotic solutions for TMS, with a more afordable and versatile solution. In 2019, Axilum Robotics became the first robotic company worldwide to receive both CE mark and FDA 510(k) clearance for a medical device using a collaborative robotic arm : TMS-Cobot The Company has customers in 20 countries and is looking for developping new medical and surgical applications with his "Cobot" platform. Axilum Robotics is ISO 13485 certified for its Quality Management System since 2013.
